1. Home
  2. CHNR vs CNSP Comparison

CHNR vs CNSP Comparison

Compare CHNR & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHNR
  • CNSP
  • Stock Information
  • Founded
  • CHNR N/A
  • CNSP 2017
  • Country
  • CHNR China
  • CNSP United States
  • Employees
  • CHNR N/A
  • CNSP N/A
  • Industry
  • CHNR Precious Metals
  • CNSP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHNR Basic Materials
  • CNSP Health Care
  • Exchange
  • CHNR Nasdaq
  • CNSP Nasdaq
  • Market Cap
  • CHNR 4.6M
  • CNSP 4.0M
  • IPO Year
  • CHNR 1995
  • CNSP 2019
  • Fundamental
  • Price
  • CHNR $3.90
  • CNSP $6.19
  • Analyst Decision
  • CHNR
  • CNSP Hold
  • Analyst Count
  • CHNR 0
  • CNSP 1
  • Target Price
  • CHNR N/A
  • CNSP N/A
  • AVG Volume (30 Days)
  • CHNR 18.0K
  • CNSP 79.4K
  • Earning Date
  • CHNR 05-15-2025
  • CNSP 08-14-2025
  • Dividend Yield
  • CHNR N/A
  • CNSP N/A
  • EPS Growth
  • CHNR N/A
  • CNSP N/A
  • EPS
  • CHNR N/A
  • CNSP N/A
  • Revenue
  • CHNR N/A
  • CNSP N/A
  • Revenue This Year
  • CHNR N/A
  • CNSP N/A
  • Revenue Next Year
  • CHNR N/A
  • CNSP N/A
  • P/E Ratio
  • CHNR N/A
  • CNSP N/A
  • Revenue Growth
  • CHNR N/A
  • CNSP N/A
  • 52 Week Low
  • CHNR $3.16
  • CNSP $4.93
  • 52 Week High
  • CHNR $9.04
  • CNSP $221.94
  • Technical
  • Relative Strength Index (RSI)
  • CHNR 54.53
  • CNSP 42.48
  • Support Level
  • CHNR $3.57
  • CNSP $5.85
  • Resistance Level
  • CHNR $4.24
  • CNSP $6.37
  • Average True Range (ATR)
  • CHNR 0.20
  • CNSP 0.68
  • MACD
  • CHNR 0.05
  • CNSP 0.13
  • Stochastic Oscillator
  • CHNR 59.04
  • CNSP 48.87

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

Share on Social Networks: